real-time news and commentary for investors
Tuesday, Nov 13
2012, 10:31 AM
Alnylam Pharmaceuticals (ALNY +4.8%) is higher this morning after reaching a settlement with...
Alnylam Pharmaceuticals (ALNY +4.8%) is higher this morning after reaching a settlement with Tekmira Pharmaceuticals (TKMR +19.3%) resolving all litigation issues between the companies. It also signed a new licensing agreement that restructures the relationship and provides clarity on all intellectual property and licensing issues. As a result, TKMR will receive $65M within 10 days and is eligible to receive an additional $10M in near-term milestone payments in 2013. (Conference Call Webcast Replay)